Vaccine Trial Design Overhaul For HIV, Malaria, Tuberculosis Is U.S. FDA/WHO Project Goal
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA grant will launch a collaborative agreement between the agency and the World Health Organization to create adaptive trial designs and explore new ways of tracking adverse event data.